Houdini Bio
Develops biotechnology approaches to tackle DNA silencing in gene therapies for use in genetic medicine development.
Overview
Houdini Bio is a biotechnology company emerging from stealth to address DNA silencing in gene therapies. Its work is positioned for the gene therapy and genetic medicine market, where silencing can limit therapeutic expression and treatment performance. The company’s stated focus on DNA silencing is its key differentiator within a competitive gene therapy landscape. Houdini Bio has raised €2M across one pre-seed round, with its June 2026 announcement citing €1.7M in funding to support its launch.
Funding History
Houdini Bio emerges from stealth with €1.7 million to tackle DNA silencing in gene therapies
Frequently Asked Questions
- How much funding does AI Funding track for Houdini Bio?
- AI Funding tracks €2M for Houdini Bio across 1 funding round in this database.
- Who are Houdini Bio's investors?
- Houdini Bio's investors include SCVC, Deep Science Ventures, Cambridge Enterprise VC.
- What does Houdini Bio do?
- Houdini Bio is a biotechnology company emerging from stealth to address DNA silencing in gene therapies. Its work is positioned for the gene therapy and genetic medicine market, where silencing can limit therapeutic expression and treatment performance. The company’s stated focus on DNA silencing is its key differentiator within a competitive gene therapy landscape. Houdini Bio has raised €2M across one pre-seed round, with its June 2026 announcement citing €1.7M in funding to support its launch.
- Where is Houdini Bio headquartered?
- Houdini Bio is headquartered in San Francisco, CA.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.